Basiliximab is superior to low dose rabbit anti-thymocyte globulin in pediatric kidney transplant recipients: The younger, the better

被引：0

作者：

Zhu Lan ^{[1
]}

Zhang Lei ^{[2
]}

Shang Wenjun ^{[3
]}

Liu Wenhua ^{[4
]}

Sa Rula ^{[1
]}

Guo Zhiliang ^{[1
]}

Liu Longshan ^{[5
]}

Tan Jinghong ^{[5
]}

Zhang Hengxi ^{[5
]}

Feng Yonghua ^{[3
]}

Zhao Wenyu ^{[2
]}

Cong Wenqi ^{[6
]}

Wu Jianyong ^{[6
]}

Wang Changxi ^{[5
]}

Chen Gang ^{[1
]}

机构：

[1] Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Key Laboratory of Organ Transplantation, Ministry of Education, NHC Key Laboratory of Organ Transplantation, Key Laboratory of Organ

[2] Department of Organ Transplantation, First Affiliated Hospital, Naval Medical University, Shanghai, China

[3] Department of Renal Transplantation, First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China

[4] Clinical Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

[5] Organ Transplant Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China

[6] Center of Nephrology, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang,

来源：

中华医学杂志英文版 | 2025年 / 138卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R726.9 [小儿泌尿科学];

学科分类号：

摘要：

<正>

引用

共 50 条

[41] Dose Reduction of Anti-Thymocyte Globulin for Kidney Transplant Induction: Possible Cost Savings?
Chaung, M.
Hollinger, E.
Brokhof, M.
Alvey, N.
Lineberger, L.
Kenyon, N.
AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 916 - 916
[42] Safety of Cumulative Dose Anti-Thymocyte Globulin in Lung Transplant
Pham, C.
Chaplain, A.
Pierce, B. J.
Nguyen, D. T.
Graviss, E. A.
Goodarzi, A.
Yau, S. W.
Youssef, J. G.
Huang, H. J.
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (04) : S372 - S373
[43] Superior Renal Allograft Survival and Decreased Rejection with Alemtuzumab Induction Compared to Rabbit Anti-Thymocyte Globulin or Basiliximab.
Gurk-Turner, Cheryle
Baig, Mirza
Munivenkatappa, Raghava B.
Klassen, David K.
Cooper, Matthew
Schweitzer, Eugene J.
Fayek, Sameh
Bartlett, Stephen T.
Philosophe, Benjamin
Barth, Rolf N.
AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 675 - 675
[44] USE OF ANTI-THYMOCYTE GLOBULIN (DOSE BY ROSETTE PROTOCOL) IN PEDIATRIC RENAL-ALLOGRAFT RECIPIENTS
UITTENBOGAART, CH
ROBINSON, BJ
MALEKZADEH, MH
PENNISI, AJ
ETTENGER, RB
FINE, RN
TRANSPLANTATION, 1979, 28 (04) : 291 - 293
[45] Efficacy of Early Steroid Withdrawal with Anti-Thymocyte Globulin Induction - Optimal Dose of Anti-Thymocyte Globulin in Korean Kidney Transplantation -
Park, J. B.
Chng, Y. S.
Kim, Y. H.
Song, K. B.
Jung, J. H.
Kim, S-C
Han, D. J.
TRANSPLANTATION, 2012, 94 (10) : 989 - 989
[46] Daclizumab versus anti-thymocyte globulin-fresenius as induction therapy for low-risk kidney transplant recipients
Abou-Jaoude, MM
Ghantous, I
Najm, R
Afif, C
Almawi, WY
TRANSPLANTATION PROCEEDINGS, 2003, 35 (07) : 2731 - 2732
[47] EARLY OUTCOMES POST RENAL TRANSPLANTATION IN LOW AND MODERATE IMMUNOLOGIC RISK RECIPIENTS FOLLOWING BASILIXIMAB OR RABBIT ANTI-THYMOCYTE GLOBULIN INDUCTION THERAPY
Salehi, T.
Clayton, P. A.
NEPHROLOGY, 2020, 25 : 80 - 80
[48] Rabbit anti-thymocyte globulin for the prevention of acute rejection in kidney transplantation
Alloway, Rita R.
Woodle, E. Steve
Abramowicz, Daniel
Segev, Dorry L.
Castan, Remi
Ilsley, Jillian N.
Jeschke, Kari
Somerville, Kenneth Troy
Brennan, Daniel C.
AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 (08) : 2252 - 2261
[49] Low-dose valganciclovir prohylaxis is efficacious and safe in cytomegalovirus seropositive heart transplant recipients with anti-thymocyte globulin
Eriksson, Mari
Jokinen, Janne J.
Soderlund, Sanni
Hammainen, Pekka
Lommi, Jyri
Lemstrom, Karl
TRANSPLANT INFECTIOUS DISEASE, 2018, 20 (03)
[50] Rabbit anti-thymocyte globulin induction in renal transplantation: A pediatric perspective
Bell, L
Burns, A
TRANSPLANTATION, 1999, 67 (07) : S184 - S184

← 1 2 3 4 5 →